Neuronetics (STIM) Revenue Growth (3y) (2020 - 2026)
Neuronetics (STIM) Revenue Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 0.73% |
| 10 | Neuronetics | 125.26 Mn | 119.25 Mn | 16.15 Mn | 30.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.40% |
| Dec 31, 2025 | 31.92% |
| Sep 30, 2025 | 31.24% |
| Jun 30, 2025 | 32.64% |
| Mar 31, 2025 | 31.13% |
| Dec 31, 2024 | 14.40% |
| Sep 30, 2024 | 10.33% |
| Jun 30, 2024 | 5.02% |
| Mar 31, 2024 | 12.33% |
| Dec 31, 2023 | 9.25% |
| Sep 30, 2023 | 12.84% |
| Jun 30, 2023 | 21.82% |
| Mar 31, 2023 | 10.63% |
| Dec 31, 2022 | 1.59% |
| Sep 30, 2022 | 1.03% |
| Jun 30, 2022 | -0.49% |
| Mar 31, 2022 | 3.67% |
| Dec 31, 2021 | -1.32% |
| Sep 30, 2021 | 0.15% |
| Jun 30, 2021 | 2.34% |